{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/cigna-group-ci/",
 "dataUrl": "https://clearank.com/stock/cigna-group-ci/data.json",
 "title": "Cigna (CI) Stock Forecast & Price Target (2026)",
 "description": "The Cigna Group (CI) stock: Healthcare, Healthcare Plans. $71.9B market cap. AI rating, technicals, 2030 forecast and trade plans.",
 "headline": "The Cigna Group (CI)",
 "published": "2026-06-21T09:11:20+00:00",
 "modified": "2026-09-26T22:01:35.663+00:00",
 "generated": "2026-09-27T15:06:01.175Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "CI",
  "name": "The Cigna Group",
  "type": "Common Stock",
  "exchange": "NYSE",
  "currency": "USD",
  "sector": "Healthcare",
  "industry": "Healthcare Plans",
  "country": "United States",
  "website": "https://www.thecignagroup.com"
 },
 "quote": {
  "price": 272.01,
  "previousClose": 265.5,
  "change": 6.51,
  "changePercent": 2.45,
  "open": 266.13,
  "high": 273.35999,
  "low": 265.35001,
  "volume": 1821800,
  "averageVolume": 1536020,
  "marketCap": 71876057239,
  "fiftyTwoWeekHigh": 315.47,
  "fiftyTwoWeekLow": 239.50999,
  "marketOpen": false,
  "asOf": "2026-09-26T22:01:35.000Z"
 },
 "statistics": {
  "pe": 11.324186,
  "eps": 23.69,
  "dividendYield": 0.022928532573744834,
  "beta": 0.317,
  "priceToSales": 0.2510351,
  "priceToBook": 1.6598504,
  "revenueTtm": 282382008320,
  "grossMargin": 0.08772200123256205,
  "returnOnEquity": 0.16758
 },
 "technicals": {
  "rsi": 39.95,
  "macd": -2.76,
  "sma50": 280.36,
  "sma200": 279.91,
  "rsiSignal": "Bearish",
  "trend": "Neutral",
  "pricePosition": "Bearish",
  "macdSignal": "Bearish",
  "rating": "Bearish"
 },
 "analysis": {
  "rating": "Hold",
  "score": 55,
  "consensus": "Hold",
  "fairValue": 340,
  "analystTarget": 340,
  "analystCount": 25,
  "wallStreetConsensus": "Buy",
  "generatedAt": "2026-09-26T22:01:35.000Z",
  "priceAtAnalysis": 272.01001,
  "volatility": {
   "daily": 1.49,
   "risk": "standard"
  }
 },
 "tradePlan": {
  "bias": "Neutral",
  "conservativeEntry": 269.29,
  "aggressiveEntry": 272.01,
  "stopLoss": 257.09,
  "stopLossPercent": 4.53,
  "targets": [
   277.37,
   282.75,
   290.83
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 196.69,
    "base": 292.19,
    "upside90th": 434.07
   },
   {
    "year": 2028,
    "downside10th": 179.34,
    "base": 313.88,
    "upside90th": 549.34
   },
   {
    "year": 2029,
    "downside10th": 169.87,
    "base": 337.17,
    "upside90th": 669.2
   },
   {
    "year": 2030,
    "downside10th": 164.12,
    "base": 362.18,
    "upside90th": 799.28
   },
   {
    "year": 2031,
    "downside10th": 160.57,
    "base": 389.06,
    "upside90th": 942.68
   },
   {
    "year": 2032,
    "downside10th": 158.51,
    "base": 417.93,
    "upside90th": 1101.88
   },
   {
    "year": 2033,
    "downside10th": 157.55,
    "base": 448.94,
    "upside90th": 1279.25
   },
   {
    "year": 2034,
    "downside10th": 157.44,
    "base": 482.25,
    "upside90th": 1477.21
   },
   {
    "year": 2035,
    "downside10th": 158.02,
    "base": 518.04,
    "upside90th": 1698.31
   },
   {
    "year": 2036,
    "downside10th": 159.18,
    "base": 556.48,
    "upside90th": 1945.35
   }
  ]
 },
 "faqCount": 7,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "CI Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$266.13",
    "Day Range": "$265.35 to $273.36",
    "Prev Close": "$265.50",
    "Volume": "1.82M",
    "52-Week Range": "$239.51 to $315.47",
    "Market Cap": "$71.88B"
   }
  },
  {
   "id": "peer-benchmarking",
   "title": "Peer Benchmarking",
   "text": [
    "Sector Position Analysis Trading at a notable discount to sector peers (-65%), which may indicate undervaluation or specific company headwinds."
   ]
  },
  {
   "id": "financials",
   "title": "CI Financial Performance",
   "text": [
    "Analysis: In the last 2 quarters, CI beat estimates 2 times. The stock rose 2 times the next day. Price tends to react positively to beats."
   ]
  },
  {
   "id": "analysis",
   "title": "CI Analysis",
   "text": [
    "The Cigna Group (CI) is trading below its 50-day and 200-day moving averages ($280.36 and $279.91), indicating a bearish trend. The Relative Strength Index (RSI) at 39.95 is in bearish territory, suggesting weakening momentum. Volume on the latest trading day was 1.82 million, 18.6% above the average, which could indicate increased selling pressure. The MACD at -2.76 also points to a bearish short-term outlook. Key support levels are not clearly defined by long-term averages, but the current price action suggests a downward bias until these averages are reclaimed.",
    "Insiders have sold over $77 million worth of The Cigna Group (CI) stock, significantly outweighing purchases of less than $1 million, leading to a 'Heavy Sell Signal'.",
    "The Cigna Group (CI) is trading below its 50-day and 200-day moving averages ($280.36 and $279.91), indicating a bearish technical trend and potential for further price declines.",
    "The median Wall Street price target for The Cigna Group (CI) is $340.00, representing a potential upside of 25.0% from the current price of $272.01.",
    "The Cigna Group (CI) trades at a P/E of 11.32 and P/S of 0.25, significantly below sector medians, suggesting potential undervaluation.",
    "The Cigna Group (CI) faces a mixed outlook, with a median Wall Street price target of $340.00 suggesting potential upside from the current $272.01. The company's forward revenue growth is estimated at around 4.00% for the upcoming quarters and years, with a projected 5-year compound annual growth rate of approximately 10.03%. The current valuation appears attractive relative to sector averages, supported by solid profitability metrics. However, the significant insider selling pressure and bearish technical indicators present considerable near-term risks. A failure to reclaim key moving averages could lead to further downside, potentially testing lower support levels. Positive catalysts would need to overcome the current insider sentiment and technical weakness to drive a sustained rally towards analyst targets."
   ],
   "lists": {
    "ProTips": [
     "Monitor insider transactions closely, as the current heavy selling pressure from insiders may indicate near-term headwinds for The Cigna Group (CI).",
     "The Cigna Group (CI) is trading below its 50-day and 200-day moving averages ($280.36 and $279.91), suggesting a bearish technical trend; consider waiting for a confirmed break above these levels before initiating new positions.",
     "Given the current bearish technicals and insider selling, risk management is paramount. Consider tighter stop-loss levels or reducing position size until a clearer bullish trend emerges."
    ]
   },
   "catalysts": [
    {
     "type": "Bearish",
     "title": "Heavy Insider Selling Pressure",
     "text": "Insiders have sold over $77 million worth of The Cigna Group (CI) stock, significantly outweighing purchases of less than $1 million, leading to a 'Heavy Sell Signal'.",
     "source": "Insider Trading Data"
    },
    {
     "type": "Bearish",
     "title": "Below Key Moving Averages",
     "text": "The Cigna Group (CI) is trading below its 50-day and 200-day moving averages ($280.36 and $279.91), indicating a bearish technical trend and potential for further price declines.",
     "source": "Technical Analysis"
    },
    {
     "type": "Bullish",
     "title": "Median Analyst Price Target Upside",
     "text": "The median Wall Street price target for The Cigna Group (CI) is $340.00, representing a potential upside of 25.0% from the current price of $272.01.",
     "source": "Wall Street Consensus"
    },
    {
     "type": "Bullish",
     "title": "Attractive Valuation Metrics",
     "text": "The Cigna Group (CI) trades at a P/E of 11.32 and P/S of 0.25, significantly below sector medians, suggesting potential undervaluation.",
     "source": "Fundamental Analysis"
    }
   ]
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "The Cigna Group (CI) exhibits a P/E ratio of 11.32, significantly lower than the healthcare sector median of 31.9, suggesting a potentially attractive valuation. Its price-to-sales ratio of 0.25 is also well below the sector average of 3.7. The company's profit margin stands at 2.27% and its return on equity is 16.76%, which is strong compared to the sector's median ROE of 6.9%. Despite the favorable valuation metrics and solid profitability, the substantial insider selling activity raises concerns about management's near-term confidence. The company's debt-to-equity ratio of 0.74 is in line with the sector average, indicating a manageable leverage position. The current valuation appears to discount near-term headwinds, but the heavy insider selling warrants careful consideration.",
    "The Cigna Group (CI) reported mixed recent earnings results. For the quarter to June 2026, the company posted an actual EPS of -$0.02 against an estimate of $0.04, a surprise of -150%, with the stock reacting positively with a 0.57% gain. Prior to that, for the quarter to June 2026, EPS was -$0.09 versus an estimate of -$0.33, a 72.73% surprise, and the stock rose 1.07%. The company has shown inconsistency in beating earnings estimates, with only one beat points.",
    "The primary risk for The Cigna Group (CI) stems from significant insider selling, with over $77 million in dispositions, signaling potential negative sentiment from management. The stock is also trading below key moving averages, indicating bearish technical momentum. Also, recent earnings have shown inconsistency, with a notable miss in the latest reported quarter."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Market Cap",
       "cells": [
        "71.88B"
       ]
      },
      {
       "label": "P/E Ratio",
       "cells": [
        "11.32"
       ]
      },
      {
       "label": "EPS (TTM)",
       "cells": [
        "23.69"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "2.27%"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "315.47"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "239.51"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Bearish RSI Bearish SMA Cross Neutral Price vs SMA Bearish MACD Bearish Price is trading below the 50-day SMA."
   ],
   "facts": {
    "RSI": "Bearish",
    "SMA Cross": "Neutral",
    "Price vs SMA": "Bearish",
    "MACD": "Bearish"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "39.95"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "-2.76"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "280.36"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "279.91"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this stock moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "+0.08",
    "Correlation with Nasdaq 100 (QQQ)": "-0.02",
    "Correlation with Bitcoin (BTC)": "+0.01",
    "Correlation with Gold (XAU)": "-0.01"
   }
  },
  {
   "id": "trade-plans",
   "title": "CI Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Enter now if confident",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (40.0) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$277.37",
    "TARGET 2": "$282.75",
    "TARGET 3": "$290.83",
    "STOP LOSS": "$257.09"
   }
  },
  {
   "id": "seasonality",
   "title": "Seasonal Patterns",
   "text": [
    "Historical monthly performance trends",
    "Based on 3 years of historical monthly returns"
   ],
   "facts": {
    "Average Jan return": "+1.61%",
    "Average Feb return": "-0.13%",
    "Average Mar return": "-2.72%",
    "Average Apr return": "+2.96%",
    "Average May return": "-0.40%",
    "Average Jun return": "+0.57%",
    "Average Jul return": "-0.07%",
    "Average Aug return": "+0.92%",
    "Average Sep return": "-0.46%",
    "Average Oct return": "+1.66%",
    "Average Nov return": "+4.63%",
    "Average Dec return": "-0.05%"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "1.49%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in CI in September 2016 would be worth about $20,869 today, compared with about $36,004 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CI today could grow to about $20,458 by 2036 in the base case, with a bull case near $71,518 and a bear case around $5,852. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "CI Stock Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $362 for CI by 2030 in the base case, from $272 today (1.3x over 4 years). The downside path ends near $164. These are outcomes of a Monte Carlo simulation run on CI's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using CI's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "CI simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$197",
        "$292",
        "$434"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$179",
        "$314",
        "$549"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$170",
        "$337",
        "$669"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$164",
        "$362",
        "$799"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$161",
        "$389",
        "$943"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$159",
        "$418",
        "$1,102"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$158",
        "$449",
        "$1,279"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$157",
        "$482",
        "$1,477"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$158",
        "$518",
        "$1,698"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$159",
        "$556",
        "$1,945"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "TEM Tempus AI Inc NASDAQ $85.01 +3.37%",
     "url": "https://clearank.com/stock/tempus-ai-tem/"
    },
    {
     "text": "ELV Elevance Health, Inc. NYSE $396.09 -0.54%",
     "url": "https://clearank.com/stock/elv-stock-analysis/"
    },
    {
     "text": "RXRX Recursion Pharmaceuticals, Inc. NASDAQ $3.74 -3.86%",
     "url": "https://clearank.com/stock/rxrx-stock-analysis/"
    },
    {
     "text": "JNJ Johnson & Johnson NYSE $271.22 +0.20%",
     "url": "https://clearank.com/stock/johnson-johnson-jnj/"
    },
    {
     "text": "DHR Danaher Corp. NYSE $224.49 +0.32%",
     "url": "https://clearank.com/stock/dhr-stock-analysis/"
    },
    {
     "text": "RMD ResMed Inc. NYSE $222.00 +0.05%",
     "url": "https://clearank.com/stock/rmd-stock-analysis/"
    },
    {
     "text": "NEOG Neogen Corp. NASDAQ $13.76 +0.73%",
     "url": "https://clearank.com/stock/neogen-neog/"
    },
    {
     "text": "HIMS Hims & Hers Health, Inc. NYSE $29.42 +0.48%",
     "url": "https://clearank.com/stock/hims-hers-health-hims/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Compare CI",
   "links": [
    {
     "text": "UNH vs CI Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/unh-vs-ci/"
    },
    {
     "text": "GLD vs GLDM Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/gld-vs-gldm/"
    },
    {
     "text": "VOO vs IVV Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/voo-vs-ivv/"
    }
   ]
  },
  {
   "id": "insider-trading",
   "title": "CI Insider Trading Analysis",
   "facts": {
    "Bought": "$999.9K",
    "Sold": "$77.0M",
    "Insiders": "18",
    "Avg Transaction": "$7.8M"
   },
   "tables": [
    {
     "caption": "Recent insider transactions in CI",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "May 12, 2026",
       "cells": [
        "CORDANI DAVID M Chief Executive Officer",
        "Sell",
        "201.9K",
        "$59.1M"
       ]
      },
      {
       "label": "Jun 8, 2020",
       "cells": [
        "CORDANI DAVID M Chief Executive Officer",
        "Sell",
        "203.1K",
        "$42.7M"
       ]
      },
      {
       "label": "Apr 15, 2021",
       "cells": [
        "CORDANI DAVID M Chief Executive Officer",
        "Sell",
        "130.4K",
        "$33.1M"
       ]
      },
      {
       "label": "May 7, 2021",
       "cells": [
        "CORDANI DAVID M Chief Executive Officer",
        "Sell",
        "62.1K",
        "$16.2M"
       ]
      },
      {
       "label": "Mar 25, 2024",
       "cells": [
        "CORDANI DAVID M Chief Executive Officer",
        "Sell",
        "39.8K",
        "$14.1M"
       ]
      },
      {
       "label": "Feb 12, 2024",
       "cells": [
        "CORDANI DAVID M Chief Executive Officer",
        "Sell",
        "40.1K",
        "$13.5M"
       ]
      },
      {
       "label": "Jan 21, 2021",
       "cells": [
        "CORDANI DAVID M Chief Executive Officer",
        "Sell",
        "55.2K",
        "$12.7M"
       ]
      },
      {
       "label": "Jan 12, 2021",
       "cells": [
        "CORDANI DAVID M Chief Executive Officer",
        "Sell",
        "55.3K",
        "$12.4M"
       ]
      },
      {
       "label": "May 17, 2022",
       "cells": [
        "CORDANI DAVID M Chief Executive Officer",
        "Sell",
        "45.3K",
        "$12.2M"
       ]
      },
      {
       "label": "Apr 20, 2022",
       "cells": [
        "CORDANI DAVID M Chief Executive Officer",
        "Sell",
        "45.4K",
        "$12.2M"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=The+Cigna+Group&type=4&dateb=&owner=include&count=40&search_text=&action=getcompany"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "Is The Cigna Group stock a buy right now?",
   "answer": "The Cigna Group (CI) is currently rated a 'Hold' with a consensus score of 55. While the median Wall Street price target of $340.00 suggests potential upside from the current price of $272.01, significant insider selling and bearish technical indicators warrant caution."
  },
  {
   "question": "What is CI's stock price forecast for 2030?",
   "answer": "Based on Monte Carlo simulations, The Cigna Group's (CI) stock price forecast for 2030 includes a base case of $362.18, a downside projection of $164.12, and an upside scenario of $799.28. These are statistical outcomes, not guarantees."
  },
  {
   "question": "How does The Cigna Group's valuation compare to its sector?",
   "answer": "The Cigna Group (CI) trades at a P/E ratio of 11.32 and a price-to-sales ratio of 0.25, which are significantly lower than the healthcare sector medians of 31.9 and 3.7, respectively, suggesting a potentially undervalued stock relative to its peers."
  },
  {
   "question": "What is the recent earnings performance of The Cigna Group?",
   "answer": "The Cigna Group (CI) reported a significant earnings miss for the quarter to June 2026, with an actual EPS of -$0.02 against an estimate of $0.04. While the stock saw a positive reaction, this follows a pattern of inconsistent earnings beats."
  },
  {
   "question": "Are insiders buying or selling The Cigna Group stock?",
   "answer": "Insiders at The Cigna Group (CI) are net sellers, with total sales exceeding $77 million compared to less than $1 million in purchases. This heavy selling pressure has resulted in a 'Heavy Sell Signal' verdict."
  },
  {
   "question": "What are the key technical indicators for CI stock?",
   "answer": "The Cigna Group (CI) is showing bearish technical signals, trading below its 50-day and 200-day moving averages ($280.36 and $279.91), with an RSI at 40.0 indicating weakening momentum and a MACD of -2.76."
  },
  {
   "question": "What is the outlook for The Cigna Group's revenue growth?",
   "answer": "The Cigna Group (CI) is projected to achieve revenue growth of approximately 4.00% for the current quarter and next quarter, with similar growth expected for the current and next year. Long-term growth estimates are around 10% annually over the next five years."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "TEM",
    "name": "Tempus AI Inc NASDAQ",
    "price": "$85.01",
    "change": "+3.37%",
    "url": "https://clearank.com/stock/tempus-ai-tem/"
   },
   {
    "ticker": "ELV",
    "name": "Elevance Health, Inc. NYSE",
    "price": "$396.09",
    "change": "-0.54%",
    "url": "https://clearank.com/stock/elv-stock-analysis/"
   },
   {
    "ticker": "RXRX",
    "name": "Recursion Pharmaceuticals, Inc. NASDAQ",
    "price": "$3.74",
    "change": "-3.86%",
    "url": "https://clearank.com/stock/rxrx-stock-analysis/"
   },
   {
    "ticker": "JNJ",
    "name": "Johnson & Johnson NYSE",
    "price": "$271.22",
    "change": "+0.20%",
    "url": "https://clearank.com/stock/johnson-johnson-jnj/"
   },
   {
    "ticker": "DHR",
    "name": "Danaher Corp. NYSE",
    "price": "$224.49",
    "change": "+0.32%",
    "url": "https://clearank.com/stock/dhr-stock-analysis/"
   },
   {
    "ticker": "RMD",
    "name": "ResMed Inc. NYSE",
    "price": "$222.00",
    "change": "+0.05%",
    "url": "https://clearank.com/stock/rmd-stock-analysis/"
   },
   {
    "ticker": "NEOG",
    "name": "Neogen Corp. NASDAQ",
    "price": "$13.76",
    "change": "+0.73%",
    "url": "https://clearank.com/stock/neogen-neog/"
   },
   {
    "ticker": "HIMS",
    "name": "Hims & Hers Health, Inc. NYSE",
    "price": "$29.42",
    "change": "+0.48%",
    "url": "https://clearank.com/stock/hims-hers-health-hims/"
   }
  ],
  "comparisons": [
   {
    "ticker": "UNH vs CI Comparison",
    "name": "",
    "url": "https://clearank.com/compare/unh-vs-ci/"
   },
   {
    "ticker": "GLD vs GLDM Comparison",
    "name": "",
    "url": "https://clearank.com/compare/gld-vs-gldm/"
   },
   {
    "ticker": "VOO vs IVV Comparison",
    "name": "",
    "url": "https://clearank.com/compare/voo-vs-ivv/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Healthcare →",
   "url": "https://clearank.com/sector/healthcare/"
  },
  "Newly Tracked": [
   {
    "ticker": "ILMN",
    "text": "Illumina Inc.",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "PCAR",
    "text": "PACCAR Inc.",
    "url": "https://clearank.com/stock/pcar-stock-analysis/"
   },
   {
    "ticker": "O",
    "text": "Realty Income Corp.",
    "url": "https://clearank.com/stock/o-stock-analysis/"
   },
   {
    "ticker": "SPG",
    "text": "Simon Property Group Inc.",
    "url": "https://clearank.com/stock/spg-stock-analysis/"
   },
   {
    "ticker": "JCI",
    "text": "Johnson Controls International",
    "url": "https://clearank.com/stock/jci-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "KAS/USD",
    "text": "↑ 11.85%",
    "url": "https://clearank.com/crypto/kaspa-kas-usd/"
   },
   {
    "ticker": "RENDER/USD",
    "text": "↑ 10.19%",
    "url": "https://clearank.com/crypto/render-render-usd/"
   },
   {
    "ticker": "ZS",
    "text": "↓ 10.06%",
    "url": "https://clearank.com/stock/zscaler-zs/"
   },
   {
    "ticker": "MXL",
    "text": "↑ 10.00%",
    "url": "https://clearank.com/stock/mxl-stock-analysis/"
   },
   {
    "ticker": "BE",
    "text": "↑ 8.27%",
    "url": "https://clearank.com/stock/be-stock-analysis/"
   }
  ],
  "Also in Healthcare": [
   {
    "ticker": "CNC",
    "text": "Centene Corporation",
    "url": "https://clearank.com/stock/centene-cnc/"
   },
   {
    "ticker": "CVS",
    "text": "CVS Health",
    "url": "https://clearank.com/stock/cvs-health-cvs/"
   },
   {
    "ticker": "ELV",
    "text": "Elevance Health",
    "url": "https://clearank.com/stock/elv-stock-analysis/"
   },
   {
    "ticker": "HUM",
    "text": "Humana Inc",
    "url": "https://clearank.com/stock/hum-stock-analysis/"
   },
   {
    "ticker": "MOH",
    "text": "Molina Healthcare Inc.",
    "url": "https://clearank.com/stock/moh-stock-analysis/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "alternateName": "CleaRank Financial AI",
     "url": "https://clearank.com",
     "description": "CleaRank is where retail traders research a trade and practice it before risking money. Its research arm, CleaRank Financial AI, publishes daily analysis, trade plans and 10-year projections for more than 1,000 stocks, ETFs, cryptocurrencies, forex pairs and commodities; each page is built from licensed market data, carries the date it was last updated and is reviewed under CleaRank's published editorial code. The CLEAR™ Score rates online brokers and prop firms on regulation, fees, platform reliability and verified trader experience. The research is free; CleaRank is paid for by subscriptions to its trading workbench (Pro $29 a month, Ultra $59 a month), which combines a live trading simulator, a trade journal that imports from broker history, an AI coach grounded in the trader's own trades, a portfolio generator, visualizer and backtester, a prop-firm challenge auditor and 22 trading calculators and scanners. Some free content contains partner links, which are disclosed and do not affect ratings.",
     "slogan": "Clear data. Honest analysis.",
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "image": {
      "@id": "https://clearank.com/#logo"
     },
     "sameAs": [
      "https://x.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank",
      "https://t.me/clearank"
     ],
     "email": "info@clearank.com",
     "contactPoint": [
      {
       "@type": "ContactPoint",
       "contactType": "customer support",
       "email": "info@clearank.com",
       "url": "https://clearank.com/contact/",
       "availableLanguage": "en"
      }
     ],
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     },
     "knowsAbout": [
      "stock analysis",
      "ETF analysis",
      "cryptocurrency analysis",
      "forex trading",
      "trading simulation",
      "trade journaling",
      "position sizing",
      "risk management",
      "prop firm challenges",
      "online broker regulation"
     ],
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "ethicsPolicy": "https://clearank.com/editorial-code/",
     "ownershipFundingInfo": "https://clearank.com/about-us/",
     "owns": {
      "@id": "https://clearank.com/#app"
     },
     "founder": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/06/ci-analysis-2026-06.png",
     "url": "https://clearank.com/wp-content/uploads/2026/06/ci-analysis-2026-06.png",
     "width": "1280",
     "height": "720",
     "caption": "The Cigna Group (CI) stock price analysis chart for June 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/cigna-group-ci/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/cigna-group-ci/",
        "name": "The Cigna Group (CI) Stock Price Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/cigna-group-ci/#webpage",
     "url": "https://clearank.com/stock/cigna-group-ci/",
     "name": "Cigna (CI) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-06-21T09:11:20+00:00",
     "dateModified": "2026-09-26T22:01:35+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/06/ci-analysis-2026-06.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/cigna-group-ci/#breadcrumb"
     },
     "reviewedBy": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "Person",
     "@id": "https://clearank.com/writer/shaundavidb/#person",
     "name": "Shaun David",
     "jobTitle": "Co-Founder",
     "url": "https://clearank.com/writer/shaundavidb/",
     "image": "https://clearank.com/media/uploads/2025/01/Shaun-David-Author-Image-.jpeg",
     "sameAs": [
      "https://www.linkedin.com/in/shaun-david-697b5817a/"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     }
    },
    {
     "@type": "Article",
     "@id": "https://clearank.com/stock/cigna-group-ci/#richSnippet",
     "headline": "Cigna (CI) Stock Forecast & Price Target (2026)",
     "name": "Cigna (CI) Stock Forecast & Price Target (2026)",
     "description": "The Cigna Group (CI) stock: Healthcare, Healthcare Plans. $71.9B market cap. AI rating, technicals, 2030 forecast and trade plans.",
     "datePublished": "2026-06-21T09:11:20+00:00",
     "dateModified": "2026-09-26T22:01:35+00:00",
     "author": {
      "@id": "https://clearank.com/#organization"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "about": {
      "@type": "Corporation",
      "name": "The Cigna Group",
      "identifier": [
       {
        "@type": "PropertyValue",
        "propertyID": "tickerSymbol",
        "value": "CI"
       },
       {
        "@type": "PropertyValue",
        "propertyID": "exchange",
        "value": "NYSE"
       }
      ],
      "description": "The Cigna Group is a global health company focused on providing health services, insurance products, and related support solutions. The company operates through two core business segments: Cigna Healthcare and Evernorth Health Services, which together serve employers, individuals, health plans, gove",
      "tickerSymbol": "CI",
      "sameAs": "https://www.thecignagroup.com"
     },
     "isPartOf": {
      "@id": "https://clearank.com/stock/cigna-group-ci/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/06/ci-analysis-2026-06.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/cigna-group-ci/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "Is The Cigna Group stock a buy right now?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The Cigna Group (CI) is currently rated a 'Hold' with a consensus score of 55. While the median Wall Street price target of $340.00 suggests potential upside from the current price of $272.01, significant insider selling and bearish technical indicators warrant caution."
     }
    },
    {
     "@type": "Question",
     "name": "What is CI's stock price forecast for 2030?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Based on Monte Carlo simulations, The Cigna Group's (CI) stock price forecast for 2030 includes a base case of $362.18, a downside projection of $164.12, and an upside scenario of $799.28. These are statistical outcomes, not guarantees."
     }
    },
    {
     "@type": "Question",
     "name": "How does The Cigna Group's valuation compare to its sector?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The Cigna Group (CI) trades at a P/E ratio of 11.32 and a price-to-sales ratio of 0.25, which are significantly lower than the healthcare sector medians of 31.9 and 3.7, respectively, suggesting a potentially undervalued stock relative to its peers."
     }
    },
    {
     "@type": "Question",
     "name": "What is the recent earnings performance of The Cigna Group?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The Cigna Group (CI) reported a significant earnings miss for the quarter to June 2026, with an actual EPS of -$0.02 against an estimate of $0.04. While the stock saw a positive reaction, this follows a pattern of inconsistent earnings beats."
     }
    },
    {
     "@type": "Question",
     "name": "Are insiders buying or selling The Cigna Group stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Insiders at The Cigna Group (CI) are net sellers, with total sales exceeding $77 million compared to less than $1 million in purchases. This heavy selling pressure has resulted in a 'Heavy Sell Signal' verdict."
     }
    },
    {
     "@type": "Question",
     "name": "What are the key technical indicators for CI stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The Cigna Group (CI) is showing bearish technical signals, trading below its 50-day and 200-day moving averages, with an RSI of 39.95 indicating weakening momentum and a MACD of -2.76."
     }
    },
    {
     "@type": "Question",
     "name": "What is the outlook for The Cigna Group's revenue growth?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The Cigna Group (CI) is projected to achieve revenue growth of approximately 4.00% for the current quarter and next quarter, with similar growth expected for the current and next year. Long-term growth estimates are around 10% annually over the next five years."
     }
    }
   ]
  }
 ]
}